Christoph Scheid

30PUBLICATIONS
191CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Transplantation immunologyMedical mycologySocial epidemiologyApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (30)

|Oct 06, 2026
BEAM versus EAM, FEAM, BeEAM, and TEAM: exploring conditioning strategies in autologous stem cell transplantation for Hodgkin lymphoma a retrospective study of the LWP of EBMT.

|Sep 30, 2026
Allogeneic hematopoietic cell transplantation for myelodysplastic syndrome in young adults: A retrospective study on behalf of the EBMT Chronic Malignancies Working Party.

|Jun 06, 2026
Impact of fludarabine dosage on outcomes in large B-cell lymphoma patients treated with CAR T-cell therapy: a retrospective study of the CTIWP of the EBMT.

|May 21, 2026
Peripheral Measurable Residual Disease Activity Assessment by MALDI-TOF Mass Spectrometry in Patients With Newly Diagnosed Multiple Myeloma in the Phase III GMMG-HD7 Trial.

|Apr 02, 2026
How to talk about death? A cross-sectional survey on patients', informal caregivers' and health care professionals' views in the setting of allogenic hematopoietic stem cell transplantation.

Lisanne Preuss, Steffen T Simon, Marco Herling

|Jan 09, 2026
Zamtocabtagene autoleucel in relapsed/refractory B-NHL: 5-year follow-up of a CD20/19 tandem CAR T-cell phase 1 trial.

Hyatt Balke-Want, Philipp Gödel, Christoph Schmid

Pageof 5

Frequent Collaborators

8 joint publications

Kavita Raj

8 joint publications

Carmelo Gurnari

7 joint publications

Hartmut Goldschmidt

6 joint publications

Marie Robin